Blog From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.By James Lu, MD, PhD, CEO and Co-Founder of Helix
Press ReleasesHelix Announces Multi-Year Agreement with Alnylam to Drive Precision Medicine DevelopmentMarch 5, 2026
Press ReleasesHelix Partners with Mawi DNA Technologies to Expand Access to Non-Invasive Genomic Sample CollectionFebruary 10, 2026
Press ReleasesHelix Announces Multi-Year Strategic Collaboration with GSK to Drive Precision Medicine DevelopmentJanuary 7, 2026
VideosPartner Perspectives with Nebraska MedicineGenetic Insights Project helps Nebraskans take charge of their health
1Published ResearchPopulation Genomic Screening Improves Lipid Management in Familial HypercholesterolemiaNovember 6, 2025
2Published ResearchPopulation Genomic Screening and Improved Lipid Management in Patients With Familial HypercholesterolemiaNovember 5, 2025
3Published ResearchFrom Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World EvidenceAugust 15, 2025
4Published ResearchNovel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse CohortJuly 30, 2025
5Published ResearchChatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering ProjectJune 10, 2025
Press ReleasesJun 27, 2023St. Luke’s University Health Network and Helix Partner on Population Genomics Research Program to Accelerate Precision Medicine
ResearchJun 17, 2023Genomewide Association Study of Severe Covid-19 with Respiratory FailureNEW ENGLAND JOURNAL OF MEDICINE
NewsJun 16, 2023San Diego startup Helix uses pandemic success to push healthcare into the futureABC10
ResearchMay 19, 2023Combining rare and common genetic variants improves population risk stratification for breast cancerMEDRXIV
NewsApr 27, 2023Twist and Shout: Helix is Weaving Population Genomics into the Healthcare FabricGenetic Engineering & Biotechnology
Blog From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.By James Lu, MD, PhD, CEO and Co-Founder of Helix
Press ReleasesHelix Announces Multi-Year Agreement with Alnylam to Drive Precision Medicine DevelopmentMarch 5, 2026
Press ReleasesHelix Partners with Mawi DNA Technologies to Expand Access to Non-Invasive Genomic Sample CollectionFebruary 10, 2026
Press ReleasesHelix Announces Multi-Year Strategic Collaboration with GSK to Drive Precision Medicine DevelopmentJanuary 7, 2026
VideosPartner Perspectives with Nebraska MedicineGenetic Insights Project helps Nebraskans take charge of their health
1Published ResearchPopulation Genomic Screening Improves Lipid Management in Familial HypercholesterolemiaNovember 6, 2025
2Published ResearchPopulation Genomic Screening and Improved Lipid Management in Patients With Familial HypercholesterolemiaNovember 5, 2025
3Published ResearchFrom Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World EvidenceAugust 15, 2025
4Published ResearchNovel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse CohortJuly 30, 2025
5Published ResearchChatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering ProjectJune 10, 2025